The focus of the symposium will be on Immuno-Oncology with the following international speakers.
Inger Andersson, Chairman of IVA’s Biotechnology – Introduction
Professor Kjell Strandberg, former DG MPA – What is immune oncology?
Magnus Jäderberg, CMO Targovax, London – The new cancer drugs in a clinical perspective
Professor Peter Nygren, Department of Oncology, University Hospital, Uppsala – Faster approvals of new drugs against cancer?
Tomas Salmonson, Chairman of the EU drugs Board (CHMP)
Bertil Jonsson, Chairman CHMP Oncology Working Party, the European Medicines Agency (EMA) London – Price, value and payment
Professor Bengt Jönsson, Stockholm School of equal access for patients to new medicines?
Mats Eriksson, Chairman of the Regional Board Region Halland – Panel Discussion Moderator
Bjorn Odlander, Managing Partner Health
Please be aware that it is required to register before 12th May at the following website.
Fore more information see here.